WSC
AGN

Wellington Shields & Co’s Allergan plc AGN Stock Holding History

Wellington Shields & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,497
Closed -$796K – 183
2020
Q1 		$796K Sell
4,497
-200
-4% -$37.7K 0.44% 64
2019
Q4 		$898K Buy
+4,697
New +$847K 0.4% 68
2019
Q3 		– Sell
-5,003
Closed -$838K – 223
2019
Q2 		$838K Sell
5,003
-100
-2% -$13.8K 0.4% 72
2019
Q1 		$747K Buy
5,103
+902
+21% +$131K 0.38% 78
2018
Q4 		$561K Buy
+4,201
New +$689K 0.32% 83

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wellington Shields & Co's AGN Position: Q2 2020 in Review

Wellington Shields & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,497 shares — an estimated $796K sold.

Wellington Shields & Co first reported a position in AGN in Q4 2018 and held it in 5 quarters. The position peaked at $898K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wellington Shields & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wellington Shields & Co sold 4,497 Allergan plc shares in Q2 2020, an estimated $796K.
  • Wellington Shields & Co first reported a position in Allergan plc in Q4 2018 and held it in 5 quarters.
  • Wellington Shields & Co's Allergan plc position peaked at $898K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wellington Shields & Co's 13F filing for Q2 2020, filed 5 Aug 2020.